These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7359146)

  • 41. Prognostic value of cerebrospinal fluid IgA and IgG in multiple sclerosis.
    Vrethem M; Fernlund I; Ernerudh J; Ohman S
    Mult Scler; 2004 Aug; 10(4):469-71. PubMed ID: 15327048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.
    Krametter D; Niederwieser G; Berghold A; Birnbaum G; Strasser-Fuchs S; Hartung HP; Archelos JJ
    Mult Scler; 2001 Feb; 7(1):13-8. PubMed ID: 11321187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease.
    Roberts-Thomson PJ; Esiri MM; Young AC; Maclennan IC
    J Clin Pathol; 1976 Dec; 29(12):1105-15. PubMed ID: 188871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The value of cerebrospinal fluid immunoglobulin analysis in clincial neurology.
    Link H
    Riv Patol Nerv Ment; 1976; 97(6):323-40. PubMed ID: 829757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myelinotoxic activity on tadpole optic nerve of cerebrospinal fluid from patients with optic neuritis.
    Stendahl-Brodin L; Link H; Kristensson K
    Neurology; 1979 Jun; 29(6):882-6. PubMed ID: 572013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.
    Mancuso R; Franciotta D; Rovaris M; Caputo D; Sala A; Hernis A; Agostini S; Calvo M; Clerici M
    Mult Scler; 2014 Dec; 20(14):1900-3. PubMed ID: 24948690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis.
    Henriksson A; Kam-Hansen S; Link H
    Clin Exp Immunol; 1985 Oct; 62(1):176-84. PubMed ID: 4064372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
    Harrer A; Tumani H; Niendorf S; Lauda F; Geis C; Weishaupt A; Kleinschnitz C; Rauer S; Kuhle J; Stangel M; Weber F; Uhr M; Linnebank M; Wildemann B; Jarius S; Guger M; Ayzenberg I; Chan A; Zettl U; Wiendl H; Pilz G; Hitzl W; Weber JR; Kraus J
    Mult Scler; 2013 Aug; 19(9):1209-12. PubMed ID: 23093485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunological parameters in multiple sclerosis].
    Igata A; Koriyama T; Matsubara H; Sano Y
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1225-8. PubMed ID: 6535676
    [No Abstract]   [Full Text] [Related]  

  • 50. Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.
    Niino M; Sato S; Fukazawa T; Yoshimura S; Hisahara S; Matsushita T; Isobe N; Yoshida K; Houzen H; Miyazaki Y; Shimohama S; Kikuchi S; Kira J
    Mult Scler; 2015 Aug; 21(9):1112-20. PubMed ID: 25583844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central nervous system IgG synthesis in multiple sclerosis. Application of a new formula.
    Schuller E; Sagar HJ
    Acta Neurol Scand; 1983 Jun; 67(6):365-71. PubMed ID: 6193673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis.
    Roström B; Link H; Laurenzi MA; Kam-Hansen S; Norrby E; Wahren B
    Ann Neurol; 1981 Jun; 9(6):569-74. PubMed ID: 7259119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Oligoclonal antibodies in the diagnosis of multiple sclerosis and other diseases of the nervous system].
    Losy J
    Neurol Neurochir Pol; 1991; 25(3):363-70. PubMed ID: 1961384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple sclerosis and intrathecal IgA synthesis.
    Sena A; Rosado P; Ferret-Sena V; Coimbra J; Schuller E; Sindic CJ
    Acta Neurol Belg; 1997 Mar; 97(1):36-8. PubMed ID: 9107343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of cerebrospinal fluid electrophoresis in optic neuritis and suspected multiple sclerosis.
    Corridori F; Salmaggi A; Bortolami C; La Mantia L; Milanese C; Campi A; Cerrato D; Nespolo A
    Ital J Neurol Sci; 1987 Jun; Suppl 6():77-80. PubMed ID: 3654181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of immunosuppressive therapy on humoral immune response in multiple sclerosis.
    Wajgt A; Górny M; Szczechowski L; Grzybowski G; Ochudło S
    Acta Med Pol; 1989; 30(3-4):121-8. PubMed ID: 2485126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immunofixation.
    Link H; Laurenzi MA
    Ann Neurol; 1979 Aug; 6(2):107-10. PubMed ID: 115379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation.
    Hershey LA; Trotter JL
    Ann Neurol; 1980 Oct; 8(4):426-34. PubMed ID: 6776879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.
    Goffette S; Schluep M; Henry H; Duprez T; Sindic CJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):308-10. PubMed ID: 14742614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.